Sofetabart
Based on 1 Customer Validation
Sofetabart (LY-4170156 Antibody) is a humanized IgG1 antibody that specifically targets folate receptor α (FRα). Sofetabart can be used to synthesize the antibody-drug conjugate (ADC) Sofetabart mipitecan. Sofetabart is applicable to research related to advanced ovarian cancer, platinum-resistant epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer, as well as platinum-sensitive ovarian cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 98.00%
- CAS. Nr.: 3066905-22-1
- Molecular Weight:145.23 kDa
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human IgG1 kappa
Human
|
FR-α |
FOLR1/FRA
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
ELISA, FACS, Functional assay
-
Loaded Sofetabart on ProA biosensor, can bind FOLR1 Protein, Human (HEK293, HY-P70296) with an affinity constant of 2.087E-08 M as determined in BLI assay.
Chemical Information
-
CAS. Nr. 3066905-22-1
-
Molecular Weight 145.23 kDa
-
Synonyms
LY-4170156 Antibody; MBK-103 Antibody
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (260 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
- Sofetabart
- 3066905-22-1
- LY-4170156 Antibody
- MBK-103 Antibody
- ADC Antibodies
- Folate Receptor (FR)
- topoisomerase-I inhibitor
- topoisomerase 1 inhibitor
- folate receptor alpha
- platinum-resistant epithelial ovarian cancer
- fallopian tube cancer
- FRα-expressing cells
- primary peritoneal cancer
- cancer cell
- advanced ovarian cancer
- platinum-sensitive ovarian cancer
- Inhibitor
- inhibitor
- inhibit